Correlation Between ABVC Biopharma and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Tempest Therapeutics, you can compare the effects of market volatilities on ABVC Biopharma and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Tempest Therapeutics.
Diversification Opportunities for ABVC Biopharma and Tempest Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ABVC and Tempest is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between ABVC Biopharma and Tempest Therapeutics
Given the investment horizon of 90 days ABVC Biopharma is expected to under-perform the Tempest Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, ABVC Biopharma is 1.12 times less risky than Tempest Therapeutics. The stock trades about -0.36 of its potential returns per unit of risk. The Tempest Therapeutics is currently generating about -0.15 of returns per unit of risk over similar time horizon. If you would invest 110.00 in Tempest Therapeutics on August 28, 2024 and sell it today you would lose (18.00) from holding Tempest Therapeutics or give up 16.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ABVC Biopharma vs. Tempest Therapeutics
Performance |
| Timeline |
| ABVC Biopharma |
| Tempest Therapeutics |
ABVC Biopharma and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ABVC Biopharma and Tempest Therapeutics
The main advantage of trading using opposite ABVC Biopharma and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Aileron Therapeutics |
| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |